Victory Capital Management
XENE icon

Victory Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History

Victory Capital Management’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.91M Buy
+49,970
New +$2.3M ﹤0.01% 1502
2023
Q3 		– Sell
-6,500
Closed -$250K – 2562
2023
Q2 		$250K Sell
6,500
-21,690
-77% -$862K ﹤0.01% 2153
2023
Q1 		$1.01M Buy
+28,190
New +$1.04M ﹤0.01% 1688
2022
Q4 		– Sell
-12,228
Closed -$441K – 2721
2022
Q3 		$441K Sell
12,228
-910
-7% -$32.7K ﹤0.01% 2102
2022
Q2 		$400K Sell
13,138
-1,126
-8% -$34.1K ﹤0.01% 2147
2022
Q1 		$403K Buy
14,264
+6,719
+89% +$201K ﹤0.01% 2205
2021
Q4 		$236K Buy
+7,545
New +$225K ﹤0.01% 2441

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return